Creatine kinase (CK) is a critical enzyme involved in cellular energy metabolism, catalyzing the reversible transfer of a phosphate group from creatine phosphate to adenosine diphosphate (ADP), producing creatine and adenosine triphosphate (ATP). Measurement of CK activity in serum is widely used in clinical diagnostics to assess muscle damage, myocardial infarction, and other pathological conditions affecting muscle tissue and the central nervous system.
Clinical Relevance
- Myocardial infarction: Elevated CK, especially the CK-MB isoenzyme, indicates cardiac muscle injury.
- Muscle diseases: Conditions such as Duchenne muscular dystrophy and rhabdomyolysis show increased CK levels.
- Neurological disorders: Some central nervous system diseases also affect CK serum concentrations.
Accurate quantification of CK activity aids in diagnosis, monitoring disease progression, and evaluating therapeutic responses.
Analytical Performance
- High sensitivity at low concentration.
- Wide dynamic range.
- Good precision, with intra- and inter-assay coefficients of variation generally below 10%.
- Rapid turnaround.
- Compatibility with various sample types, including serum, plasma, and tissue homogenates.
Creatine kinase assay kits for serum provide a robust, sensitive, and clinically relevant method for measuring CK activity. Their principles enable precise quantification essential for diagnosing and monitoring muscle and cardiac diseases. Advances in assay design continue to improve throughput, accuracy, and ease of use, supporting their popular application in clinical and research settings.
